落新婦苷
分析標(biāo)準(zhǔn)品,HPLC≥98%
Astilbin
CAS號(hào)：29838-67-3
分子式：C21H22O11
分子量：450.4
MDL：MFCD20274680
貨號(hào) | 規(guī)格/參數(shù)/品牌 | 價(jià)格 | 貨期 |
YJ-B20812-20mg | 分析標(biāo)準(zhǔn)品,HPLC≥98% | ￥350.00 | 現(xiàn)貨 |
YJ-B20812-1g | 分析標(biāo)準(zhǔn)品,HPLC≥98% | ￥3580.00 | 現(xiàn)貨 |
產(chǎn)品介紹
熔點(diǎn)：180 ℃ (decomp)
沸點(diǎn)：801.1 oC at 760 mmHg
外觀：無色晶體
溶解性：DMSO：50mg/ml
儲(chǔ)存條件：2-8℃
注意：部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權(quán)威性，僅供客戶參考交流研究之用。
參考文獻(xiàn)(37篇)
37. [IF=4.8] Haixing Feng et al."Astilbin from Smilax china L. remarkably inhibits LPS-induced endometritis in rats via blocking positive feedback between TLR4 and IL-6R signalling pathways in a PPAR-γ-dependent manner."JOURNAL OF ETHNOPHARMACOLOGY.2025 Apr;:119861
36. [IF=4.7] Zhengyao Yu et al."Exploring the Therapeutic and Gut Microbiota-Modulating Effects of Qingreliangxuefang on IMQ-Induced Psoriasis."Drug Design Development and Therapy.
35. [IF=6.8] Guangliang Shi et al."The antagonism mechanism of astilbin against cadmium-induced injury in chicken lungs via Treg/Th1 balance signaling pathway."ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY".2024 Jun;277:116364
34. [IF=5.4] Yingxue Guo et al."Integrated network pharmacological analysis revealed that Smilax glabra Roxb. alleviates IMQ-induced psoriatic skin inflammation through regulating T cell immune response."JOURNAL OF ETHNOPHARMACOLOGY".2024 May;325:117836
33. [IF=6.8] Yue Zhu et al."Astilbin antagonizes developmental cardiotoxicity after cadmium exposure in chicken embryos by inhibiting endoplasmic reticulum stress and maintaining calcium homeostasis."ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY.2024 Jan;270:115847
32. [IF=7.2] Zhao Fang et al."Astilbin protects from sepsis-induced cardiac injury through the NRF2/HO-1 and TLR4/NF-κB pathway."PHYTOTHERAPY RESEARCH.2023 Dec;:
31. [IF=5.4] Mingxiang Xie et al."Molecular mechanism of PSORI-CM01 for psoriasis by regulating the inflammatory cytokines network."JOURNAL OF ETHNOPHARMACOLOGY.2024 Jan;318:116935
30. [IF=6.656] Chong Chen et al."Yishen-Qingli-Huoxue Formula attenuates renal fibrosis by inhibiting indoxyl sulfate via AhR/snai1 signaling."PHYTOMEDICINE.2022 Nov;:154546
29. [IF=5.396] Tingwei Wang et al."Astilbin from Smilax glabra Roxb. alleviates high-fat diet-induced metabolic dysfunction."Food Funct. 2022 Apr;:
28. [IF=1.216] Han Yan et al."Studies on the Anti-Gouty Arthritis and Anti-hyperuricemia Properties of Astilbin in Animal Models."Open Chem. 2020 Jan;18(1):207-214
27. [IF=3.297] Mao Yang et al."Astilbin influences the progression of osteoarthritis in rats by down-regulation of PGE-2 expression via the NF-κB pathway."Ann Transl Med. 2020 Jun; 8(12): 766
26. [IF=3.69] Qianni Duan et al."Antiviral effect of Chinese herbal prescription JieZe-1 on adhesion and penetration of VK2/E6E7 with herpes simplex viruses type 2."J Ethnopharmacol. 2020 Mar;249:112405
25. [IF=4.225] Wen Xianghui et al."Qu-Zhuo-Tong-Bi Decoction Alleviates Gouty Arthritis by Regulating Butyrate-Producing Bacteria in Mice."Front Pharmacol. 2021 Feb;11:2508
24. [IF=6.529] Xue Chen et al."Dendrobium officinalis six nostrum ameliorates urate under-excretion and protects renal dysfunction in lipid emulsion-induced hyperuricemic rats."Biomed Pharmacother. 2020 Dec;132:110765
23. [IF=2.398] Hui Bi et al."Analgesic effects of astilbin partially via calcium channels through regulation on CaMKII."Food Agr Immunol. 2019;30(1):309-319
22. [IF=3.775] Si-wei Wang et al."Astilbin ameliorates cisplatin-induced nephrotoxicity through reducing oxidative stress and inflammation."Food Chem Toxicol. 2018 Apr;114:227
21. [IF=3.906] Xiaoqi Sun et al."Caspase-dependent mitochondrial apoptotic pathway is involved in astilbin-mediated cytotoxicity in breast carcinoma cells."Oncol Rep. 2018 Oct;40(4):2278-2286
20. [IF=4.36] Yueqin Cai et al."Medicinal effect and its JP2/RyR2-based mechanism of Smilax glabra flavonoids on angiotensin II-induced hypertrophy model of cardiomyocytes."J Ethnopharmacol. 2015 Jul;169:435
19. Duan, Qianni, et al. "Antiviral effect of Chinese herbal prescription JieZe-1 on adhesion and penetration of VK2/E6E7 with herpes simplex viruses type 2." Journal of ethnopharmacology 249 (2020): 112405.https:##doi.org/10.1016/j.jep.2019.112405
18. Hui Bi, Zhen Sun, Qiubo Chu, Lanzhou Li, Xin Guan, Yulin Zhou & Zhiwen Li (2019) Analgesic effects of astilbin partially via calcium channels through regulation on CaMKII, Food and Agricultural Immunology, 30:1, 309-319, DOI: 10.1080/09540105.2019.1580677
17. Wang, Si-wei, et al. "Astilbin ameliorates cisplatin-induced nephrotoxicity through reducing oxidative stress and inflammation." Food and chemical toxicology 114 (2018): 227-236.https:##doi.org/10.1016/j.fct.2018.02.041
16. Yang, Mao, et al. "Astilbin influences the progression of osteoarthritis in rats by down-regulation of PGE-2 expression via the NF-κB pathway." Annals of Translational Medicine 8.12 (2020).https:##dx.doi.org/10.21037%2Fatm-20-4485
15. Sun, Xiaoqi, et al. "Caspase-dependent mitochondrial apoptotic pathway is involved in astilbin-mediated cytotoxicity in breast carcinoma cells." Oncology reports 40.4 (2018): 2278-2286.https:##doi.org/10.3892/or.2018.6602
14. 王夢(mèng)雪,戴寒鵬,李金明,蘇婭,韓欣然,李麗.土茯苓抑制CYP3A4酶活性的研究[J].長春師范大學(xué)學(xué)報(bào),2020,39(08):60-63.
13. 馮麗敏, 趙瑞芝, 王銀潔,等. 正交設(shè)計(jì)法優(yōu)選銀屑靈片中腫節(jié)風(fēng)有效成分的提取工藝[J]. 時(shí)珍國醫(yī)國藥, 2011(08):1860-1861.
12. 趙瑞芝,王銀潔,馮麗敏,盧傳堅(jiān).大鼠口服芍苓消銀片后血液中芍藥苷、落新婦苷、迷迭香酸、異嗪皮啶、甘草苷的藥物動(dòng)力學(xué)研究[J].中國中藥雜志,2014,39(13):2559-2563.
11. 楊俊杰,張艷玲,王崢濤,陸兔林.土茯苓產(chǎn)地加工過程中去皮的合理性分析[J].中國實(shí)驗(yàn)方劑學(xué)雜志,2017,23(03):1-5.
10. 楊俊杰, 黃紫炎, 李林,等. 土茯苓產(chǎn)地加工與炮制一體化工藝優(yōu)選[J]. 時(shí)珍國醫(yī)國藥, 2018, 29(09):2165-2168.
9. 潘馨 衷林清 周楚楚 等. HPLC同時(shí)測(cè)定草珊瑚中9個(gè)有效成分的含量[J]. 藥物分析雜志 2017 037(007):1207-1214.
8. 馮麗敏 趙瑞芝 盧傳堅(jiān). HPLC同時(shí)測(cè)定芍苓消銀片中芍藥苷 落新婦苷 綠原酸 迷迭香酸和甘草酸的含量[J]. 中國現(xiàn)代應(yīng)用藥學(xué) 2014 031(009):1097-1101.
7. 鄒靜 陳慧 彭懿 等. HPLC法同時(shí)測(cè)定加味二妙顆粒中7種成分及指紋圖譜建立[J]. 中成藥 2018 v.40(02):99-104.
6. 王銀潔, 趙瑞芝, 盧傳堅(jiān). 銀屑靈與土茯苓中落新婦苷大鼠體內(nèi)的藥代動(dòng)力學(xué)比較[J]. 中國中藥雜志, 2012, 37(12):1859-1861.
5. 徐萍,張淼,徐玉彬,毛旭南,張培建.落新婦苷預(yù)處理對(duì)大鼠肝臟缺血再灌注損傷和Bcl-2、Bax表達(dá)的影響[J].中國藥師,2016,19(11):2055-2058.
4. 黃慧輝, 張小燕, 沈娟,等. 菝葜抗炎有效部位群在大鼠腸外翻試驗(yàn)中的吸收特性考察[J]. 中國實(shí)驗(yàn)方劑學(xué)雜志, 2016, v.22(08):96-99.
3. 趙瑞芝, 史長燦, 劉麗娟,等. 芍苓消銀緩釋片Beagle犬體內(nèi)藥物動(dòng)力學(xué)評(píng)價(jià)[J]. 中國醫(yī)院藥學(xué)雜志, 2017, 11(v.37):17-19.
2. 王思為, 張峰, 鄭曉燕,等. 土茯苓活性分子落新婦苷聯(lián)合順鉑對(duì)人肺癌A549細(xì)胞凋亡的影響[J]. 中藥材, 2017(12).
1. 姜宣羽, 王思為, 樓麗君,等. 土茯苓活性分子落新婦苷抗順鉑誘導(dǎo)的人腎小管上皮細(xì)胞凋亡作用研究[J]. 浙江中西醫(yī)結(jié)合雜志, 2018, 28(09):735-738.
